Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Filtered Value Type Gene Rank description green Network Comparison Type Interaction Map red network_comparison
Results: HTML CSV LaTeX Showing element 51 to 100 of 38536 in total 
Filtered: 0
Value Type: Measured
Network Comparison Type: Divided

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
26\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
fatty acid desaturase 1; linoleoyl-coa desaturase (delta-6-desaturase)-like 1; delta-5 desaturase; delta-5 fatty acid desaturase. [source:refseq;acc:nm\_013402]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
662\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
153\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
4.3268\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
glucosamine-6-phosphate isomerase (ec 3.5.99.6) (glucosamine-6- phosphate deaminase) (gnpda) (glcn6p deaminase) (oscillin). [source:swissprot;acc:p46926]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
47\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
143\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.04255\vspace{3pt}}\\\cline{1-3}\cline{5-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
27\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma antigen, family d, 4 isoform 1; mage1 protein; mage-e1 protein; maged4 protein. [source:refseq;acc:nm\_030801]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
phenylethanolamine n-methyltransferase (ec 2.1.1.28) (pnmtase) (noradrenaline n-methyltransferase). [source:swissprot;acc:p11086]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
139\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
570\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
4.10072\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
28\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
beta-carotene dioxygenase 2; putative b,b-carotene-9',10'-dioxygenase. [source:refseq;acc:nm\_031938]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 3 (mage-3 antigen) (antigen mz2-d). [source:swissprot;acc:p43357]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
105.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
29\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 11 (mage-11 antigen). [source:swissprot;acc:p43364]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
potassium voltage-gated channel, shal-related subfamily, member 2; voltage-sensitive potassium channel; voltage-gated potassium channel kv4.2. [source:refseq;acc:nm\_012281]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
434.911\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
111.278\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.90833\vspace{3pt}}\\\cline{1-3}\cline{5-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
30\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dystrophin. [source:swissprot;acc:p11532]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
111.739\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
427.217\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.82335\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 2 (mage-2 antigen). [source:swissprot;acc:p43356]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
31\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
dok-like protein. [source:refseq;acc:nm\_024872]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
35\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3500000\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
hepatocellular carcinoma-associated protein hca1. [source:refseq;acc:nm\_020932]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
32\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
cell division protein kinase 8 (ec 2.7.1.-) (protein kinase k35). [source:swissprot;acc:p49336]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
184\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
598\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.25\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 6 (mage-6 antigen) (mage3b). [source:swissprot;acc:p43360]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
33\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
lim domain binding 1; carboxy terminal lim domain protein 2; lim domain-binding factor-1. [source:refseq;acc:nm\_003893]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
39.8063\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
12.6208\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.15402\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen d1 (mage-d1 antigen) (neurotrophin receptor-interacting mage homolog) (pro2292). [source:swissprot;acc:q9y5v3]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
34\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
glucosamine-6-phosphate isomerase (ec 3.5.99.6) (glucosamine-6- phosphate deaminase) (gnpda) (glcn6p deaminase) (oscillin). [source:swissprot;acc:p46926]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
47\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
143\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
3.04255\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen f1 (mage-f1 antigen). [source:swissprot;acc:q9hay2]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
35\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
adp,atp carrier protein, liver isoform t2 (adp/atp translocase 3) (adenine nucleotide translocator 3) (ant 3). [source:swissprot;acc:p12236]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1377\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
459.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.99674\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 4 (mage-4 antigen) (mage-x2) (mage-41). [source:swissprot;acc:p43358]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
36\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
heparan sulfate 6-o-sulfotransferase 2. [source:refseq;acc:nm\_147174]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
157\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.80357\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 9 (mage-9 antigen). [source:swissprot;acc:p43362]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
37\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
1,4-alpha-glucan branching enzyme (ec 2.4.1.18) (glycogen branching enzyme) (brancher enzyme). [source:swissprot;acc:q04446]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
934.348\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
334.401\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.79409\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 8 (mage-8 antigen). [source:swissprot;acc:p43361]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
105.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
38\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen c1 (mage-c1 antigen) (cancer-testis antigen ct7). [source:swissprot;acc:o60732]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein slug (neural crest transcription factor slug) (snail homolog 2). [source:swissprot;acc:o43623]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
120.429\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
320.012\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.65727\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
39\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 12 (mage-12 antigen) (mage12f). [source:swissprot;acc:p43365]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
microtubule-associated protein, rp/eb family, member 2; t-cell activation protein, eb1 family; apc-binding protein eb1. [source:refseq;acc:nm\_014268]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
192.295\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
482.426\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.50878\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
40\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 1 (mage-1 antigen) (antigen mz2-e). [source:swissprot;acc:p43355]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nanos (fragment). [source:sptrembl;acc:q8wy41]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
151\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
377\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.49669\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
41\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen 10 (mage-10 antigen). [source:swissprot;acc:p43363]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase 13 kda-b subunit (ec 1.6.5.3) (ec 1.6.99.3) (complex i-13kd-b) (ci-13kd-b) (complex i subunit b13). [source:swissprot;acc:q16718]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
645\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
266\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.42481\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
42\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen b1 (mage-b1 antigen) (mage-xp antigen) (dss-ahc critical interval mage superfamily 10) (dam10). [source:swissprot;acc:p43366]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
presenilin enhancer 2; hematopoietic stem/progenitor cells protein mds033. [source:refseq;acc:nm\_172341]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
86.9525\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.439\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.36266\vspace{3pt}}\\\cline{1-3}\cline{5-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
43\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
elongation factor ts, mitochondrial precursor (ef-ts) (ef-tsmt). [source:swissprot;acc:p43897]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
587.988\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
263.66\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.2301\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
melanoma-associated antigen d2 (mage-d2 antigen) (breast cancer associated gene 1 protein) (bcg-1) (11b6) (hepatocellular carcinoma associated protein jcl-1). [source:swissprot;acc:q9unf1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
35.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
105.5\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.97183\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
44\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
acyl-coa dehydrogenase, short/branched chain specific, mitochondrial precursor (ec 1.3.99.-) (sbcad) (2-methyl branched chain acyl-coa dehydrogenase) (2-mebcad) (2-methylbutyryl-coenzyme a dehydrogenase) (2-methylbutyryl-coa dehydrogenase). [source:swissprot;acc:p45954]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
98.5074\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
45.4292\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.16837\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenic locus notch homolog protein 1 precursor (notch 1) (hn1) (translocation-associated notch protein tan-1). [source:swissprot;acc:p46531]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.00001\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
286\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
28600000\vspace{3pt}}}\\\cline{1-2}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
45\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenic locus notch homolog protein 2 precursor (notch 2) (hn2). [source:swissprot;acc:q04721]\vspace{3pt}}&&&&\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tigger transposable element derived 6. [source:refseq;acc:nm\_030953]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
438.605\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.374\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.1673\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
46\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ephrin type-b receptor 4 precursor (ec 2.7.1.112) (tyrosine-protein kinase receptor htk). [source:swissprot;acc:p54760]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
24\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.79167\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tigger transposable element derived 7; jerky (mouse) homolog-like. [source:refseq;acc:nm\_033208]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
438.035\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.163\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.16674\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
47\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
tenascin-x precursor (tn-x) (hexabrachion-like). [source:swissprot;acc:p22105]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
776.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
310.103\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.50526\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
tigger transposable element derived 1; jerky (mouse) homolog-like. [source:refseq;acc:nm\_145702]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
438.016\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
202.156\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.16672\vspace{3pt}}\\\cline{1-3}\cline{5-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
48\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
deltex homolog 1; hdx-1. [source:refseq;acc:nm\_004416]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
403.196\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
870.482\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.15895\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
pnas-129. [source:sptrembl;acc:q9bxv8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
151.073\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
366.666\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.42708\vspace{3pt}}\\\cline{1-3}\cline{5-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
49\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
nadh-ubiquinone oxidoreductase 13 kda-b subunit (ec 1.6.5.3) (ec 1.6.99.3) (complex i-13kd-b) (ci-13kd-b) (complex i subunit b13). [source:swissprot;acc:q16718]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
645\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
266\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.42481\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
selenide,water dikinase 2 (ec 2.7.9.3) (selenophosphate synthetase 2) (selenium donor protein 2). [source:swissprot;acc:q99611]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
151\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
72\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.09722\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
50\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
latrophilin 2; lectomedin-1; latrophilin homolog 2 (cow). [source:refseq;acc:nm\_012302]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
111\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
262\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.36036\vspace{3pt}}\\\cline{2-6}
&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor 4 (immunoglobulin transcription factor 2) (itf-2) (sl3-3 enhancer factor 2) (sef-2). [source:swissprot;acc:p15884]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
44\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
2.09524\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/